According to the Enterprise Research App, recently, Puhua Fengqi Phase II Venture Capital Fund partnership was established with an investment amount of 210 million yuan. The business scope includes venture capital. According to enterprise research and equity penetration, the partnership is jointly owned by Zhejiang Pharmaceuticals and Zhejiang Puhua Tianqin Equity Investment Management Co., Ltd., an affiliate of Pratt & Whitney Capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.